Arthur Donny Strosberg

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Founded in 2002, Natixis Securities Americas LLC is an investment bank and SEC-registered broker/dealer headquartered New York City with offices in several leading U.S. cities and affiliate offices in London and Paris. The firm is a division of Natixis and a subsidiary of Natixis SA. Their client base is located throughout North America and Europe and ranges from the largest mutual fund and pension fund managers to specialist hedge funds. Natixis Securities Americas' sales and trading teams are located in New York, Boston, Los Angeles and Houston. Natixis Securities Americas' research efforts focus on identifying new insights about companies that are not fully reflected in their stock prices. The firm also seeks to provide clients with access to the managements of listed companies and to other industry experts. They arrange for such marketing opportunities, in the form of road shows, conferences, meetings and conference calls. Natixis Securities Americas' institutional trading desk offers clients trading capabilities in equities all over the world. The firm focuses on specific global markets to provide clients with the best possible execution worldwide. Natixis Securities Americas employs a transatlantic approach that examines the effects of technological, market and regulatory developments across both continents on the companies under coverage. In the U.S., they provide in-depth sector coverage on energy (oil services, exploration and production, alternative energy and coal), healthcare (large-cap pharmaceuticals, specialty pharmaceuticals, biotechnology, medical devices and healthcare services) and media (media conglomerates, content creators, interactive TV and new media, as well as technical analysis. In Europe, Natixis Securities Americas applies a country-wide approach to all of the key sectors of France, Germany, Austria and Central and Eastern Europe. Combined, the firm's product offering includes more than 600 stocks. Natixis Securities Americas global trading group specializes in the trading, execution and settlement of international equities. The firm provides 24-hour access to 55 global markets. They cater to broker/dealer and institutional clients, providing ADR and ordinary share executions on an agency or proprietary basis. The firm can accommodate most client trading requirements from basket trading to block orders. To complement their international trading reach, Natixis Securities Americas domestic bulletin board trading group currently markets over 2000 U.S.-based companies. The firm offers their clients innovative trading technology through a proprietary Direct Market Access (DMA) platform, Enabler Direct. This product allows immediate access to a variety of liquidity sources through one anonymous interface. Natixis Securities Americas' global brokerage services group offers services to a select group of professional clients. The firm seeks to partner with banks, broker/dealers, hedge funds and high net-worth clients that can utilize their blend of international capabilities and traditional brokerage services to support and enhance their success. Their global brokerage services group is prominent in international securities, equity trading and brokerage operations in over 55 countries around the world. They have experience in both the pre-trade and post-trade requirements in each of these countries.

Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK.

Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021.

Founded in 1995, Teva Santé SAS is a subsidiary of Teva Pharmaceutical Industries Ltd. that develops and markets medicines and therapeutic solutions. The company is based in Paris, France.

Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France.

Part of Next Alt SARL, Business FM SAS is a French company that operates a radio station. The company is based in Paris, France. The company was founded in 2000. The CEO is Arthur Clément Dreyfuss.

Part of Liberty Global Ltd., Time Warner Cable France is a French company that provides cable television services. The company is based in Paris, France. Time Warner Cable France was acquired by United Pan-Europe Communications NV from Time Warner, Inc. on April 01, 1999 for $75.26 million.

Part of Compagnie Financière Richemont SA, Van Cleef & Arpels is a French company that sells jewelry, watches, and precious metals. The company is based in Paris, France. Van Cleef & Arpels was acquired by Compagnie Financière Richemont SA on January 29, 2003.

SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France.

Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Part of AbbVie, Inc., Fournier Laboratories Ireland Ltd. is an Irish company that manufactures pharmaceutical preparations. The company is based in Carrigtwohill, Ireland.

Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom.

Saint Jean Industries Lorraine SAS specializes in the design and the production of prototype parts. The firm offers molded housings for the automotive, hydraulic components and agro alimentary industries. The company was founded in 1983 and is headquartered in Harol, France.